444 related articles for article (PubMed ID: 30572962)
1. A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis.
Du Preez S; Corbitt M; Cabanas H; Eaton N; Staines D; Marshall-Gradisnik S
Syst Rev; 2018 Dec; 7(1):241. PubMed ID: 30572962
[TBL] [Abstract][Full Text] [Related]
2. Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome.
Giloteaux L; Goodrich JK; Walters WA; Levine SM; Ley RE; Hanson MR
Microbiome; 2016 Jun; 4(1):30. PubMed ID: 27338587
[TBL] [Abstract][Full Text] [Related]
3. A Narrative Review on Gut Microbiome Disturbances and Microbial Preparations in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Long COVID.
Jurek JM; Castro-Marrero J
Nutrients; 2024 May; 16(11):. PubMed ID: 38892479
[TBL] [Abstract][Full Text] [Related]
4. Assessing severity of illness and outcomes of treatment in children with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME): a systematic review of patient-reported outcome measures (PROMs).
Haywood KL; Collin SM; Crawley E
Child Care Health Dev; 2014 Nov; 40(6):806-24. PubMed ID: 24661148
[TBL] [Abstract][Full Text] [Related]
5. Children's experiences of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review and meta-ethnography of qualitative studies.
Parslow RM; Harris S; Broughton J; Alattas A; Crawley E; Haywood K; Shaw A
BMJ Open; 2017 Jan; 7(1):e012633. PubMed ID: 28087544
[TBL] [Abstract][Full Text] [Related]
6. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease.
Arron HE; Marsh BD; Kell DB; Khan MA; Jaeger BR; Pretorius E
Front Immunol; 2024; 15():1386607. PubMed ID: 38887284
[TBL] [Abstract][Full Text] [Related]
7. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome.
Nagy-Szakal D; Williams BL; Mishra N; Che X; Lee B; Bateman L; Klimas NG; Komaroff AL; Levine S; Montoya JG; Peterson DL; Ramanan D; Jain K; Eddy ML; Hornig M; Lipkin WI
Microbiome; 2017 Apr; 5(1):44. PubMed ID: 28441964
[TBL] [Abstract][Full Text] [Related]
8. High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients.
Frémont M; Coomans D; Massart S; De Meirleir K
Anaerobe; 2013 Aug; 22():50-6. PubMed ID: 23791918
[TBL] [Abstract][Full Text] [Related]
9. Eukaryotes in the gut microbiota in myalgic encephalomyelitis/chronic fatigue syndrome.
Mandarano AH; Giloteaux L; Keller BA; Levine SM; Hanson MR
PeerJ; 2018; 6():e4282. PubMed ID: 29375937
[TBL] [Abstract][Full Text] [Related]
10. Important factors to consider when treating children with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): perspectives of health professionals from specialist services.
Parslow RM; Shaw A; Haywood KL; Crawley E
BMC Pediatr; 2017 Feb; 17(1):43. PubMed ID: 28143516
[TBL] [Abstract][Full Text] [Related]
11. A critical analysis of the proposal of the Institute of Medicine to replace myalgic encephalomyelitis and chronic fatigue syndrome by a new diagnostic entity called systemic exertion intolerance disease.
Twisk FN
Curr Med Res Opin; 2015; 31(7):1333-47. PubMed ID: 25912615
[TBL] [Abstract][Full Text] [Related]
12. The gastrointestinal microbiota in the development of ME/CFS: a critical view and potential perspectives.
Stallmach A; Quickert S; Puta C; Reuken PA
Front Immunol; 2024; 15():1352744. PubMed ID: 38605969
[TBL] [Abstract][Full Text] [Related]
13. Problems in defining post-exertional malaise.
Jason LA; Evans M; So S; Scott J; Brown A
J Prev Interv Community; 2015; 43(1):20-31. PubMed ID: 25584525
[TBL] [Abstract][Full Text] [Related]
14. Symptoms, impairment and illness intrusiveness--their relationship with depression in women with CFS/ME.
Dancey CP; Friend J
Psychol Health; 2008; 23(8):983-99. PubMed ID: 25160923
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
Maes M; Twisk FN; Ringel K
Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
[TBL] [Abstract][Full Text] [Related]
16. In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation.
Maes M; Ringel K; Kubera M; Anderson G; Morris G; Galecki P; Geffard M
J Affect Disord; 2013 Sep; 150(2):223-30. PubMed ID: 23664637
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care.
Nacul LC; Lacerda EM; Pheby D; Campion P; Molokhia M; Fayyaz S; Leite JC; Poland F; Howe A; Drachler ML
BMC Med; 2011 Jul; 9():91. PubMed ID: 21794183
[TBL] [Abstract][Full Text] [Related]
18. Interventions in pediatric chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review.
Knight SJ; Scheinberg A; Harvey AR
J Adolesc Health; 2013 Aug; 53(2):154-65. PubMed ID: 23643337
[TBL] [Abstract][Full Text] [Related]
19. Experiences of daily activity in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and their implications for rehabilitation programmes.
Pemberton S; Cox DL
Disabil Rehabil; 2014; 36(21):1790-7. PubMed ID: 24369769
[TBL] [Abstract][Full Text] [Related]
20. Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin.
Maes M; Twisk FN; Kubera M; Ringel K
J Affect Disord; 2012 Feb; 136(3):933-9. PubMed ID: 21975140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
